Facebook
Twitter
Telegram
Report an ErrorCorcept Therapeutics Incorporated Financial Ratios 2011-2024 | CORT
Annual Financial Ratios Corcept Therapeutics Incorporated
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
24.0 | 22.0 | 20.4 | 28.5 | 15.8 | 17.9 | 20.8 | 100.5 | -60.9 | -9.4 | -8.1 | -5.1 | -8.8 |
P/S |
5.3 | 5.6 | 6.3 | 8.5 | 4.9 | 5.4 | 16.9 | 10.1 | 7.8 | 11.1 | 35.9 | 58.5 | - |
EPS |
1.0 | 0.9 | 1.0 | 0.9 | 0.8 | 0.7 | 1.1 | 0.1 | -0.1 | -0.3 | -0.5 | -0.4 | -0.4 |
EV (Enterprise Value) |
2.52 B | 2.25 B | 2.26 B | 2.99 B | 1.5 B | 1.34 B | 2.69 B | 794 M | 383 M | 308 M | 360 M | 138 M | 249 M |
EBITDA per Share |
1.04 | 1.06 | 1.09 | 1.12 | 0.995 | 0.778 | 0.467 | 0.0928 | -0.0308 | -0.272 | -0.415 | -0.39 | -0.388 |
EV/EBITDA |
17.3 | 24.5 | 12.8 | 14.6 | 50.2 | 76.1 | -110.9 | -10.2 | -7.8 | -2.8 | -7.5 | ||
PEG |
3.61 | 1.08 | 0.2 | 1.32 | 0.6 | -0.42 | 0.01 | 0.45 | -0.75 | -0.29 | 0.66 | 0.99 | 3.33 |
P/B |
5.0 | 4.4 | 6.1 | 5.8 | 4.0 | 4.9 | 14.1 | 19.8 | 21.1 | -86.7 | 17.7 | 3.1 | 8.1 |
P/CF |
20.0 | 18.5 | 13.6 | 19.9 | 11.0 | 11.7 | 44.4 | 45.0 | 125.3 | -10.7 | -10.0 | -5.3 | -10.3 |
ROE % |
20.95 | 20.21 | 29.94 | 20.26 | 25.37 | 27.33 | 67.61 | 19.67 | -34.64 | 926.30 | -218.92 | -61.59 | -92.95 |
ROA % |
17.08 | 17.38 | 26.55 | 18.54 | 22.84 | 24.19 | 58.55 | 11.84 | -12.34 | -90.62 | -72.94 | -38.37 | -81.22 |
ROCE % |
21.17 | 22.44 | 33.12 | 24.50 | 29.88 | 32.41 | 27.68 | 24.60 | -11.08 | -131.05 | -82.43 | -39.94 | -92.89 |
Current Ratio |
5.4 | 7.2 | 8.8 | 11.8 | 7.9 | 6.7 | 4.2 | 2.4 | 2.3 | 2.2 | 4.6 | 11.4 | 7.9 |
DSO |
27.3 | 26.6 | 26.8 | 23.8 | 23.7 | 25.6 | 64.6 | 44.3 | 45.2 | 45.8 | 50.3 | 61.5 | - |
DIO |
389.4 | 375.8 | 342.1 | 337.9 | 359.7 | 331.2 | 470.0 | 413.1 | 451.1 | 499.5 | 2797.5 | 3421.4 | - |
DPO |
827.1 | 640.0 | 603.4 | 591.5 | 499.8 | 578.5 | 881.1 | 406.1 | 355.3 | 780.5 | 6077.4 | 15257.8 | - |
Operating Cycle |
416.8 | 402.4 | 368.9 | 361.6 | 383.4 | 356.7 | 534.6 | 457.3 | 496.2 | 545.3 | 2847.8 | 3482.9 | - |
Cash Conversion Cycle |
-410.3 | -237.6 | -234.6 | -229.8 | -116.4 | -221.8 | -346.5 | 51.2 | 140.9 | -235.2 | -3229.6 | -11775.0 | - |
All numbers in USD currency
Quarterly Financial Ratios Corcept Therapeutics Incorporated
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.27 | 0.31 | 0.27 | 0.15 | - | 0.32 | 0.26 | 0.22 | - | 0.26 | 0.23 | 0.2 | 0.22 | 0.19 | 0.25 | 0.26 | 0.26 | 0.23 | 0.18 | 0.16 | 0.19 | 0.15 | 0.16 | 0.15 | 0.86 | 0.12 | 0.11 | 0.04 | 0.04 | 0.02 | 0.01 | - | 0.01 | -0.01 | -0.02 | -0.05 | -0.04 | -0.06 | -0.07 | -0.14 | -0.11 | -0.11 | -0.12 | -0.12 | -0.11 | -0.08 | -0.09 | -0.13 | -0.12 | -0.08 | -0.11 | -0.09 |
EBITDA per Share |
0.29 | - | - | 0.14 | - | 0.3 | 0.3 | 0.26 | - | 0.32 | 0.27 | 0.17 | - | 0.22 | 0.31 | 0.33 | - | 0.29 | 0.22 | 0.17 | - | 0.2 | 0.18 | 0.18 | - | 0.12 | 0.11 | 0.04 | - | 0.03 | 0.01 | 0.01 | - | - | -0.01 | -0.04 | - | -0.05 | -0.06 | -0.13 | - | -0.1 | -0.11 | -0.11 | - | -0.08 | -0.09 | -0.13 | - | -0.08 | -0.11 | - |
ROE % |
21.39 | 23.64 | 24.15 | 23.82 | 19.10 | 24.74 | 23.07 | 21.95 | 15.31 | 20.28 | 18.77 | 19.11 | 20.26 | 23.21 | 26.17 | 26.19 | 25.37 | 25.44 | 24.77 | 25.93 | 27.33 | 70.85 | 71.62 | 71.65 | 67.61 | 27.23 | 26.28 | 22.02 | 19.67 | 13.75 | 4.25 | -8.58 | -34.64 | 75.14 | 255.66 | 489.03 | 926.30 | 758.41 | 529.24 | 249.73 | -218.92 | -184.00 | -145.53 | -101.22 | -61.59 | -72.13 | -77.19 | -90.41 | -92.95 | -18.49 | -25.52 | -20.40 |
ROA % |
17.33 | 19.59 | 20.80 | 20.42 | 16.23 | 21.43 | 15.28 | 19.95 | 14.12 | 18.67 | 17.24 | 17.53 | 18.54 | 21.12 | 23.73 | 23.67 | 22.84 | 22.78 | 22.08 | 23.02 | 24.19 | 61.72 | 62.26 | 62.16 | 58.55 | 20.65 | 18.17 | 13.86 | 11.84 | 7.00 | 2.08 | -3.07 | -12.35 | -25.44 | -41.63 | -59.70 | -90.62 | -97.01 | -96.96 | -94.01 | -72.94 | -66.53 | -57.60 | -46.40 | -38.37 | -52.09 | -59.89 | -74.52 | -81.22 | -16.15 | -22.30 | -17.83 |
ROCE % |
21.96 | 23.32 | 23.31 | 23.40 | 20.42 | 27.12 | 27.08 | 26.09 | 16.66 | 21.39 | 19.40 | 20.03 | 18.67 | 27.56 | 31.73 | 31.63 | 20.63 | 28.96 | 28.39 | 29.24 | 23.42 | 30.55 | 29.36 | 28.58 | 16.32 | 23.74 | 24.03 | 20.97 | 12.50 | 13.05 | 6.18 | -3.77 | -27.54 | 123.08 | 273.15 | 473.70 | 724.41 | 678.07 | 481.10 | 235.55 | -149.72 | -162.13 | -128.21 | -89.19 | -42.56 | -61.05 | -67.13 | -80.32 | -64.37 | -18.49 | -25.48 | -20.39 |
Current Ratio |
6.1 | 4.5 | 5.1 | 7.0 | - | 8.9 | - | 7.8 | 8.8 | 13.0 | 12.4 | 13.3 | 11.8 | 11.8 | 11.8 | 11.8 | 10.0 | 10.0 | 10.0 | 10.0 | 8.7 | 8.7 | 8.7 | 8.7 | 7.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
29.9 | 24.8 | 25.2 | 14.1 | - | 13.2 | 12.0 | 26.7 | - | 25.7 | 24.8 | 27.8 | 27.9 | 27.7 | 27.0 | 22.6 | 20.7 | 22.3 | 25.2 | 26.4 | 24.0 | 24.9 | 25.8 | 26.0 | 26.2 | 32.6 | 39.3 | 41.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
264.6 | 400.2 | 386.2 | 211.0 | - | 206.0 | 176.1 | 367.4 | - | 345.8 | 317.0 | 354.7 | - | 368.4 | 363.1 | 251.1 | - | 341.1 | 359.4 | 373.7 | - | 330.1 | 374.2 | 361.7 | - | 427.8 | 538.8 | - | - | - | - | - | - | 599.5 | 349.6 | 436.5 | - | 468.7 | 512.3 | 603.9 | - | 2500.2 | 4348.3 | 4446.2 | - | 3243.2 | 1621.6 | - | - | - | - | - |
DPO |
526.8 | 684.7 | 556.3 | 369.2 | - | 278.7 | 321.4 | 590.5 | - | 564.5 | 533.6 | 630.5 | - | 792.0 | 780.4 | 439.5 | - | 474.0 | 499.5 | 581.5 | - | 576.7 | 653.6 | 654.6 | - | 802.1 | 1010.1 | - | - | - | - | - | - | 472.3 | 275.4 | 485.1 | - | 732.3 | 800.5 | 1118.9 | - | 5431.7 | 9446.4 | 14109.5 | - | 14463.1 | 7231.6 | - | - | - | - | - |
Operating Cycle |
294.5 | 425.0 | 411.5 | 225.0 | - | 219.2 | 188.1 | 394.1 | - | 371.5 | 341.9 | 382.5 | 27.9 | 396.1 | 390.1 | 273.6 | 20.7 | 363.4 | 384.6 | 400.1 | 24.0 | 355.0 | 399.9 | 387.8 | 26.2 | 460.5 | 578.0 | 41.6 | - | - | - | - | - | 599.5 | 349.6 | 436.5 | - | 468.7 | 512.3 | 603.9 | - | 2500.2 | 4348.3 | 4446.2 | - | 3243.2 | 1621.6 | - | - | - | - | - |
Cash Conversion Cycle |
-232.2 | -259.7 | -144.8 | -144.2 | - | -59.5 | -133.3 | -196.3 | - | -193.0 | -191.7 | -248.0 | 27.9 | -395.8 | -390.4 | -165.9 | 20.7 | -110.6 | -114.9 | -181.4 | 24.0 | -221.6 | -253.7 | -266.9 | 26.2 | -341.6 | -432.1 | 41.6 | - | - | - | - | - | 127.2 | 74.2 | -48.6 | - | -263.6 | -288.2 | -515.0 | - | -2931.4 | -5098.1 | -9663.4 | - | -11219.9 | -5610.0 | - | - | - | - | - |
All numbers in USD currency